[Form 4] Health Catalyst, Inc Insider Trading Activity

Rhea-AI Filing Summary

Health Catalyst, Inc. (HCAT) – Form 4 Insider Filing

Director Jill Hoggard Green reported the grant of 36,231 restricted stock units (RSUs) on 9 July 2025 under the company’s 2019 Stock Option and Incentive Plan. Each RSU represents one share of common stock that will fully vest on the earlier of (i) one-year from the grant date or (ii) the next annual shareholder meeting.

• Transaction type: Acquisition (A) – no cash consideration; price reported as $0.00.
• Post-transaction ownership: 63,937 common shares held directly.
• Role of insider: Non-employee Director; this award appears to be routine board compensation.

The filing shows no sales or derivative activity, indicating the insider increased her economic exposure to HCAT equity. While insider purchases can signal confidence, the size of this grant is typical for board equity compensation and does not materially affect the company’s capital structure.

Positive

• Director Jill Hoggard Green acquired 36,231 RSUs, increasing her direct ownership to 63,937 shares and aligning interests with shareholders.

Negative

• None.

Insights

Corporate Governance Analyst

TL;DR: Routine RSU grant to director; positive alignment but limited market impact.

The reported Form 4 details a standard annual equity grant to Director Jill Hoggard Green. Because the award vests within one year or at the next AGM, it strengthens board-shareholder alignment without creating immediate dilution—36,231 shares represent <0.1% of the 57 million shares outstanding. No open-market purchase or sale occurred, so the transaction does not convey a valuation view. For investors, the filing is neutral: it confirms regular governance practices but lacks financial or strategic implications significant enough to move the stock.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hoggard Green Jill

(Last) (First) (Middle)

C/O HEALTH CATALYST, INC.

10897 SOUTH RIVER FRONT PARKWAY, #300

(Street)

SOUTH JORDAN UT 84095

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Health Catalyst, Inc. [ HCAT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
07/09/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/09/2025		A		36,231(1)	A	$0.00	63,937	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents an award of restricted stock units ("RSUs") granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan, the RSUs will fully vest on the earlier of (i) the one-year anniversary of the grant date or (ii) the date of the next Annual Meeting of the Issuer's Stockholders.

Remarks:

	/s/ Benjamin Landry, as Attorney-in-Fact	07/10/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

Who is the insider in the HCAT Form 4 filing?

Jill Hoggard Green, a director of Health Catalyst, Inc.

What type of securities were granted to the insider?

The filing reports 36,231 restricted stock units (RSUs).

When were the RSUs granted?

The grant date was July 9, 2025.

When will the RSUs vest?

They vest on the earlier of one year from grant or the next annual shareholder meeting.

How many HCAT shares does the director own after the grant?

The director now holds 63,937 common shares directly.

Did the insider pay for the shares?

No; the RSUs were granted at $0.00 cost as part of board compensation.